Low Her2 Expression Does Not Influence Prognosis in Metastatic Triple-Negative Breast Cancer: Results from an International, Multicenter Analysis Coordinated by the Austrian Group Medical Tumor Therapy (Agmt)
AuthID
P-00W-NJX
P-00W-NJX